Monika Fischer
Expertise in
28
conditions

Dr. Monika Fischer

Gastroenterology
Indiana University Health University Hospital
550 University Blvd, 
Indianapolis, IN 
Offers Telehealth
Expertise in
28
conditions
Indiana University Health University Hospital
550 University Blvd, 
Indianapolis, IN 

Overview

Monika Fischer is a Gastroenterologist practicing medicine in Indianapolis, Indiana.

Dr. Fischer is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Crohn's Disease, Ulcerative Colitis, Pseudomembranous Colitis, Colonoscopy, and Endoscopy.

She is actively involved in clinical research, co-authoring 125 peer reviewed articles and participating in 10 clinical trials.

Specialties

Gastroenterology

Licenses

General Acute Care Hospital in IN

Hospital Affiliations

Indiana University Health Bedford Hospital
Indiana University Health
Indiana University Health Ball Memorial Hospital
Iu Health West Hospital
Indiana University Health North Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
MDwise
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Indiana University Health University Hospital
550 University Blvd, Indianapolis, IN 46202

Additional Areas of Focus

Dr. Fischer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Small Intestinal Bacterial Overgrowth: A Prospective Registry
Small Intestinal Bacterial Overgrowth: A Prospective Registry
Enrollment Status: Enrolling_by_invitation
Publish Date: June 16, 2026
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: December 15, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
A Phase 4 Study Evaluating Real-World Use of CDPATH™, a Crohn's Disease Risk Prediction Tool
Enrollment Status: Active_not_recruiting
Publish Date: November 05, 2025
Intervention Type: Other
Study Phase: Phase 4
Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study
Non-invasive Vagus Nerve Stimulation in the Treatment of Crohn's Disease - A Pilot Study
Enrollment Status: Terminated
Publish Date: March 06, 2025
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease
Open Label, Randomized, Multicenter, Comparative Effectiveness Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission in Patients With Crohn's Disease
Enrollment Status: Completed
Publish Date: July 21, 2021
Intervention Type: Other
Study Phase: Not Applicable
Safety of Fecal Microbiota Transplantation: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
Safety of Fecal Microbiota Transplantation: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection
Enrollment Status: Terminated
Publish Date: February 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
Phase II Randomized, Double Blind, Placebo-controlled, Parallel Group Trial of Encapsulated Fecal Microbiota Transplantation for Vancomycin Resistant Enterococcus Decolonization
Phase II Randomized, Double Blind, Placebo-controlled, Parallel Group Trial of Encapsulated Fecal Microbiota Transplantation for Vancomycin Resistant Enterococcus Decolonization
Enrollment Status: Completed
Publish Date: April 13, 2020
Intervention Type: Biological
Study Phase: Phase 2
A Pilot Study to Evaluate if Response to Infliximab or Adalimumab May be Regained With the Addition of an Immunomodulator
A Pilot Study to Evaluate if Response to Infliximab or Adalimumab May be Regained With the Addition of an Immunomodulator
Enrollment Status: Terminated
Publish Date: November 04, 2019
Intervention Type: Drug
Study Phase: Not Applicable
View 9 Less Clinical Trials

125 Total Publications

Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study.
Impact of mirikizumab treatment on fatigue in patients with moderately to severely active Crohn's disease: results from the phase 3 VIVID-1 study.
Journal: Journal of Crohn's & colitis
Published: June 10, 2025
Similar Doctors
Expertise in
28
conditions
Dr. Evan Fogel
Gastroenterology
Expertise in
28
conditions
Dr. Evan Fogel
Gastroenterology
Referral may be required

Indiana University Health University Hospital

550 University Blvd, 
Indianapolis, IN 
 (1.2 miles away)
317-278-6997
Languages Spoken:
English
See accepted insurances

Evan Fogel is a Gastroenterologist practicing medicine in Indianapolis, Indiana. Dr. Fogel is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Hereditary Pancreatitis, Chronic Pancreatitis, Sphincter of Oddi Dysfunction, Endoscopy, and Lithotripsy.

Expertise in
37
conditions
Dr. Raj Vuppalanchi
Gastroenterology
Expertise in
37
conditions
Dr. Raj Vuppalanchi
Gastroenterology
Referral may be required

Indiana University Health University Hospital

550 University Blvd, 
Indianapolis, IN 
 (1.2 miles away)
317-944-0980
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Raj Vuppalanchi is a Gastroenterologist practicing medicine in Indianapolis, Indiana. Dr. Vuppalanchi is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis (NASH), Cirrhosis, Liver Transplant, and Gastric Bypass.

Expertise in
39
conditions
Dr. Douglas Rex
Gastroenterology
Expertise in
39
conditions
Dr. Douglas Rex
Gastroenterology
Referral may be required

Indiana University Health University Hospital

550 University Blvd, 
Indianapolis, IN 
 (1.2 miles away)
317-944-8660
Languages Spoken:
English
See accepted insurances

Douglas Rex is a Gastroenterologist practicing medicine in Indianapolis, Indiana. Dr. Rex is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Colorectal Polyps, Colorectal Cancer, Familial Adenomatous Polyposis, Colonoscopy, and Endoscopy.

Frequently Asked Questions about Dr. Monika Fischer

How do I make an appointment with Dr. Monika Fischer?

You can book an appointment with Dr. Monika Fischer by calling their office at 317-944-0980. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Monika Fischer a top-rated expert for Crohn's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Monika Fischer is classified as an Elite expert for Crohn's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Monika Fischer specialize in?

While Dr. Monika Fischer is a Gastroenterology, they have specific expertise in Crohn's Disease, Ulcerative Colitis, and Pseudomembranous Colitis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Monika Fischer participate in research or clinical trials?

Yes. Dr. Monika Fischer has published 125 articles and abstracts on conditions like Crohn's Disease. You can view a list of Dr. Monika Fischer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Monika Fischer accept my insurance?

Dr. Monika Fischer accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 317-944-0980 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fischer's expertise for a condition
ConditionClose
View All 19 Advanced Conditions
View All 63 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile